JP5858418B2 - 花粉症ワクチンの治療効果を予測するバイオマーカー - Google Patents

花粉症ワクチンの治療効果を予測するバイオマーカー Download PDF

Info

Publication number
JP5858418B2
JP5858418B2 JP2011076653A JP2011076653A JP5858418B2 JP 5858418 B2 JP5858418 B2 JP 5858418B2 JP 2011076653 A JP2011076653 A JP 2011076653A JP 2011076653 A JP2011076653 A JP 2011076653A JP 5858418 B2 JP5858418 B2 JP 5858418B2
Authority
JP
Japan
Prior art keywords
nucleic acid
pollen
vaccine
cedar
ccl2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011076653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012210167A5 (enExample
JP2012210167A (ja
Inventor
美孝 岡本
美孝 岡本
絢子 稲嶺
絢子 稲嶺
茂俊 堀口
茂俊 堀口
大樹 櫻井
大樹 櫻井
俊憲 中山
俊憲 中山
野中　謙
謙 野中
政克 山下
政克 山下
小原　收
收 小原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiba University NUC
Kazusa DNA Research Institute Foundation
Original Assignee
Chiba University NUC
Kazusa DNA Research Institute Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiba University NUC, Kazusa DNA Research Institute Foundation filed Critical Chiba University NUC
Priority to JP2011076653A priority Critical patent/JP5858418B2/ja
Publication of JP2012210167A publication Critical patent/JP2012210167A/ja
Publication of JP2012210167A5 publication Critical patent/JP2012210167A5/ja
Application granted granted Critical
Publication of JP5858418B2 publication Critical patent/JP5858418B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2011076653A 2011-03-30 2011-03-30 花粉症ワクチンの治療効果を予測するバイオマーカー Active JP5858418B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011076653A JP5858418B2 (ja) 2011-03-30 2011-03-30 花粉症ワクチンの治療効果を予測するバイオマーカー

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011076653A JP5858418B2 (ja) 2011-03-30 2011-03-30 花粉症ワクチンの治療効果を予測するバイオマーカー

Publications (3)

Publication Number Publication Date
JP2012210167A JP2012210167A (ja) 2012-11-01
JP2012210167A5 JP2012210167A5 (enExample) 2014-05-29
JP5858418B2 true JP5858418B2 (ja) 2016-02-10

Family

ID=47264709

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011076653A Active JP5858418B2 (ja) 2011-03-30 2011-03-30 花粉症ワクチンの治療効果を予測するバイオマーカー

Country Status (1)

Country Link
JP (1) JP5858418B2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6447991B2 (ja) * 2014-08-28 2019-01-09 国立大学法人千葉大学 花粉症減感作療法の治療効果を予測する方法及び診断薬

Also Published As

Publication number Publication date
JP2012210167A (ja) 2012-11-01

Similar Documents

Publication Publication Date Title
Cevhertas et al. Advances and recent developments in asthma in 2020
KR20210084528A (ko) I형 인터페론 시그너처 및 사용 방법
Aslanian-Kalkhoran et al. The effect of lymphocyte immunotherapy (LIT) in modulating immune responses in patients with recurrent pregnancy loss (RPL)
US8629108B2 (en) Rheumatoid arthritis T cell vaccine
WO2011051402A1 (en) New biomarkers for determining allergy status
Aharoni et al. Glatiramer acetate increases T-and B-regulatory cells and decreases granulocyte-macrophage colony-stimulating factor (GM-CSF) in an animal model of multiple sclerosis
WO2016066770A1 (en) Markers of immune response
US20180230463A1 (en) Compounds and Methods for the Treatment of Inflammatory Diseases of the CNS
Grupper et al. Humoral response to the third dose of Sars-Cov-2 vaccine in kidney transplant recipients
ES2826385T3 (es) IL-10 como biomarcador pronóstico de la sensibilidad a la inmunoterapia con alérgenos de ácaros del polvo doméstico
EP3922641A1 (en) Methods for detecting and treating covid patients requiring intensive care
JP5858418B2 (ja) 花粉症ワクチンの治療効果を予測するバイオマーカー
JP2013021932A (ja) 関節リウマチに対する抗ｉｌ−６受容体抗体療法の有効性の予測方法
US20210262032A1 (en) Determining responders to inflammation treatment
WO2009103319A2 (en) Proteins ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis vulgaris and poststreptococcal diseases
Figueroa et al. Restriction in the usage of variable β regions in T-cells infiltrating valvular tissue from rheumatic heart disease patients
US10226470B2 (en) DGAT1 inhibition for treatment of demyelinating inflammatory disease
JP6447991B2 (ja) 花粉症減感作療法の治療効果を予測する方法及び診断薬
Slavyanskaya CANCER CHECKPOINT BLOCKADE
TONG et al. Heat shock proteins mRNA expressions by peripheral blood mononuclear cells in asthma and chronic bronchitis
JP2009210420A (ja) アレルギー疾患の治療薬且つ治療効果のマーカー
BAI et al. Analysis of the T cell receptor Vδ region gene repertoire in bronchoalveolar lavage fluid (BALF) and peripheral blood of asthmatics
Roberts et al. Developments in the field of allergy in 2016 through the eyes of Clinical and Experimental Allergy
EP3825695A2 (en) Biomarkers for responders to ait
Lahesmaa Allergen-induced in vitro expression of IL-18, SLAM and GATA-3 mRNA in PBMC during sublingual immunotherapy

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140329

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20140329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20140329

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150526

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150724

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151117

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151209

R150 Certificate of patent or registration of utility model

Ref document number: 5858418

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250